{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:08:47Z","timestamp":1787497727073,"version":"build-2736575974"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,7,15]]},"DOI":"10.2169\/internalmedicine.4943-20","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T17:08:00Z","timestamp":1613927280000},"page":"2255-2260","source":"Crossref","is-referenced-by-count":5,"title":["Anti-glomerular Basement Membrane Disease with Antiphospholipid Syndrome"],"prefix":"10.2169","volume":"60","author":[{"given":"Miki","family":"Torigoe","sequence":"first","affiliation":[{"name":"Department of Nephrology, Nagasaki University Hospital, Japan"},{"name":"Department of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Obata","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineaki","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagasaki University Hospital, Japan"},{"name":"Department of Blood Purification, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kobe University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Fukuoka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagasaki University Hospital, Japan"},{"name":"Department of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. McAdoo SP, Pusey CD. Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol 12: 1162-1172, 2017.","DOI":"10.2215\/CJN.01380217"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 346: 752-763, 2002.","DOI":"10.1056\/NEJMra002974"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Adhikari A, Chisti MM, Bastola S, Kc O. Rare case of catastrophic antiphospholipid syndrome with spontaneous intracranial haemorrhage. BMJ Case Rep 12: 3227171, 2019.","DOI":"10.1136\/bcr-2018-227171"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 66: 1535-1540, 2004.","DOI":"10.1111\/j.1523-1755.2004.00917.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Basford AW, Lewis J, Dwyer JP, Fogo AB. Membranous nephropathy with crescents. J Am Soc Nephrol 22: 1804-1808, 2011.","DOI":"10.1681\/ASN.2010090923"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Longano A. Concurrent anti-GBM disease and IgA glomerulonephritis. Pathology 51: 336-338, 2019.","DOI":"10.1016\/j.pathol.2018.09.065"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nochy D, Daugas E, Deoz D, et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10: 507-518, 1999.","DOI":"10.1681\/ASN.V103507"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sinico RA, Cavazzana I, Nuzzo M, et al. Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients. Clin J Am Soc Nephrol 5: 1211-1217, 2010.","DOI":"10.2215\/CJN.00460110"},{"key":"9","unstructured":"9. Jennette JC, D'Agati VD, Olson JL, Silva FG. Heptinstall's pathology of the kidney. 7th ed. Wolters Kluwer, Alphen aan den Rijn, Netherlands, 2014: 739-782."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Fischer MJ, Rauch J, Levine JS. The antiphospholipid syndrome. Semin Nephrol 27: 35-46, 2007.","DOI":"10.1016\/j.semnephrol.2006.09.006"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Asherson RA, Cervera R, de Groot PG, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12: 530-534, 2003.","DOI":"10.1191\/0961203303lu394oa"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Rodriguez-Pinto I, Moitinho M, Santacreu I, et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry. Autoimmun Rev 15: 1120-1124, 2016.","DOI":"10.1016\/j.autrev.2016.09.010"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Renard D, Dutrav A, Le Quellec A, Milhaud D. Reversible posterior leukoencephalopathy syndrome in catastrophic antiphospholipid syndrome. Cerebrovasc Dis 24: 141-143, 2007.","DOI":"10.1159\/000103618"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Olson SW, Arbogast CB, Baker TP, et al. Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. J Am Soc Nephrol 22: 1945-1952, 2011.","DOI":"10.1681\/ASN.2010090928"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Serratrice J, Chiche L, Dussol B, et al. Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis. Am J Kidney 43: e26-e30, 2004.","DOI":"10.1053\/j.ajkd.2003.11.019"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Matsuura E, Shen L, Matsunami Y, et al. Pathophysiology of \u03b22-glycoprotien I in antiphospholipid syndrome. Lupus 19: 379-384, 2010.","DOI":"10.1177\/0961203310361352"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Terryn W, Benoit D, Van Loo A, et al. Goodpasture's syndrome associated with autoimmune thrombotic thrombocytopenic purpura-an unusual case. Nephrol Dial Transplant 22: 3672-3673, 2007.","DOI":"10.1093\/ndt\/gfm483"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Manabe S, Banno M, Nakano M, et al. A case of PR3-ANCA-positive anti-GBM disease associated with intrarenal arteritis and thrombotic microangiopathy. CEN Case Rep 6: 39-45, 2017.","DOI":"10.1007\/s13730-016-0240-3"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Levy JB, Turney AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasmas exchange and immunosuppression. Ann Intern Med 134: 1033-1042, 2001.","DOI":"10.7326\/0003-4819-134-11-200106050-00009"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/14\/60_4943-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:36:45Z","timestamp":1715128605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/14\/60_4943-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":19,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4943-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"article-number":"4943-20"}}